Articles

In the European Union and the United Kingdom, aflibercept 8 mg (Eylea HD in the US) is currently approved for neovascular age-related macular degeneration and diabetic macular oedema

Social determinants of health challenge our existing expectations

Patients with GCA, an autoimmune disease, are at risk for sudden vision loss which can be permanent

Following Phase 3 pivotal trial BRIO-II, Tenpoint Therapeutics said they hope to launch BRIMOCHOL PF in 2026

The study findings support the need to consider ophthalmologic monitoring in children with early-onset atopic dermatitis

Nordic Pharma plans to announce commercialisation details in the near future for the dry eye disease treatment

Fundus images of diabetic retinopathy were assessed by general ophthalmologists, retina specialists and the Aireen artificial intelligence system

Retina topics serve as the backbone of the scientific programme at this year’s Congress on Controversies in Ophthalmology

Regulatory agencies issued approvals for new treatments and expanded uses of existing therapies in the retina space

Aldeyra previously received a CRL for its initial New Drug Application for reproxalap in November 2023

Both trials failed to meet their primary endpoints for treatment of age-related macular degeneration

How studies into myopia management can increase access to vision care

A pivotal phase 3 clinical trial found that SYD-101 met its 3-year primary endpoint for slowing paediatric myopia progression

Hematologists and ophthalmologists could work together for earlier diagnoses, research findings indicate

Dr. Arnaldo Espaillat decided to undergo ZEISS PRESBYOND and shares how his own experience led him to expand his refractive portfolio with this corneal-based approach for patients without cataracts.

This year, the COPHy meeting moves beyond retina, addressing uveitis, neuro-ophthalmology and glaucoma in Seville, Spain

Researchers assessed the costs to patients and caregivers in Germany, Bulgaria and the US

A resurgence in this IOL technology could create new possibilities in refractive correction

The study assessed a large paediatric cohort for changes in spherical equivalent refraction, axial length, lens power and lens thickness

AURN001 is Aurion Biotech's clinical-stage allogeneic cell therapy asset for corneal oedema secondary to corneal endothelial disease

The approval makes ILM-Blue the first DORC posterior dye product available in China, according to a press release from Zeiss

The authors examined vascular and neural structures in the eye, assessing the foveal avascular zone and choroidal thickness

The synthetic opsin was packaged into an optimised AAV2 gene therapy vector that targets human retinal bipolar cells.

The lens will be available with the Monarch IV manual delivery system in Q2 and the AutonoMe Automated Pre-Loaded Delivery System in Q3

The partnership will use ocular imaging to build an AI foundation model and identify new genetic targets for degenerative diseases

The Combination OPT-302 with Aflibercept Study (COAST) evaluated sozinibercept 2 mg in combination with aflibercept 2 mg for wet age-related macular degeneration

The study demonstrated that the number of injections needed gradually decreased during the follow-up period

The study findings indicated that lifestyle changes associated with the COVID-19 pandemic were connected to an increase in childhood astigmatisms

Inherited retinal diseases have disease processes distinct from age-related macular degeneration and geographic atrophy, but may present with "phenocopy" clinical signs

The award recipients are leading research projects in India, Italy and Mexico